Psychae Therapeutics

About:

Psychae Therapeutics focuses on developing medical-grade, botanically derived treatments to address serious mental health challenges.

Website: https://www.psychae.bio/

Top Investors: University of Melbourne, Tin Alley Ventures

Description:

Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses

Total Funding Amount:

4.5M AUD

Headquarters Location:

Carlton, Victoria, Australia

Founded Date:

2022-01-01

Contact Email:

team(AT)psychae.bio

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-11-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai